## Abstract The original article to which this Erratum refers was published in __Molecular Carcinogenesis__ 2004;40:122–133.Molecular Carcinogenesis 2004;40:122–133
Mutation frequencies in murine keratinocytes as a function of carcinogenic status
✍ Scribed by Laura A. Christensen; Claudio J. Conti; Susan M. Fischer; Karen M. Vasquez
- Book ID
- 102501700
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 186 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20026
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A link between genetic abnormalities and carcinogenesis is well established. It follows that a correlation exists between mutation frequency and malignant progression. We have determined the spontaneous and DNA damage–induced mutation frequencies for a series of cell lines derived from SENCAR mouse keratinocytes at various stages of malignant progression. Nontumorigenic mouse keratinocytes (3PC), papillomas (MT1/2), squamous‐cell carcinomas (CH72), and spindle‐cell carcinomas (CH72T4) were transfected with damaged or undamaged shuttle vectors containing a supF mutation reporter gene. The plasmid mutation frequencies were determined by blue/white screening. The spontaneous plasmid mutation frequency of the squamous‐cell carcinoma line was slightly higher than the mutation frequencies of the other cell lines tested. The DNA damage induced by triplex‐directed psoralen crosslinks increased the mutation frequencies sixfold to eighteenfold in all cell lines tested, with no significant differences among the cell lines. Sequence analyses revealed that the spindle‐cell carcinoma line had a different spontaneous mutation spectrum from the other cell lines. DNA damage–induced mutations were predominantly point mutations at the triplex‐duplex junction in all of the cell lines tested, as expected. These data suggested that a strong mutator phenotype was not required for progression to an advanced malignant phenotype in our model system. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES